On a mini hiring spree, CRO Altasciences nabs ex-Charles River exec

Canadian pharmaceuticals
Canadian CRO Altasciences also added a new chief scientific officer just last month. (Shutterstock)

Just a month ago, Altasciences grabbed CRO veteran Beatrice Setnik, Ph.D., as its new chief scientific officer; now, it’s at it again.

The Canadian biopharma services company said it has hired Lynne LeSauteur, Ph.D., as its vice president of immunochemistry and immunology.

LeSauteur comes out of the Human Health Therapeutics Research Center at the National Research Council of Canada where she helped discover, biomanufacture and characterize new biologics alongside life sciences companies.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

RELATED: Syneos Health exec jumps ship to Canadian CRO Altasciences

Before this, she served a stint at fellow CRO Charles River Labs, where she established its immunology department.

Marie-Hélène Raigneau, EVP of research services at Altasciences, said: “We are extremely pleased to welcome Lynne to the team at Altasciences. The breadth of her experience in both preclinical and clinical drug development, including her in-depth knowledge of immunotoxicology, immunogenicity, immunoassays, molecular biology, and biomarkers, will continue to enhance scientific guidance to our growing base of small- to mid-size clients.”

Suggested Articles

The facility, to be based in the new life sciences center One Discovery Square, is expected to open before the end of this year.

The FDA announced plans to join two collaborative communities focused on real-world evidence and ophthalmic imaging.

Panelists at the CAR-TCR Summit reflected on gender diversity trends and the challenges women face in the life sciences industry.